Cancer related adverse events associated with use of proton pump inhibitors and histamine-2 receptor antagonists: A real-world analysis using the FDA adverse event reporting system - Bowen Wang; Zheyun Song; Shan Lan; Xiubi Chen; Xida Yan; Xue-Feng Jiao (PLoS ONE, 2025)